Clinical Trial Update: Omadacycline vs. Moxifloxacin for the Treatment of Community-Acquired Bacterial Pneumonia [Phase 3]

View source ↗

Summary

Phase 3 trial comparing omadacycline to moxifloxacin for community-acquired bacterial pneumonia has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Pneumonia
• Community-acquired Pneumonia

Drugs mentioned

• Avelox (moxifloxacin) (moxifloxacin)
• Nuzyra (omadacycline) (omadacycline)

Snippet

Sponsor: Paratek Pharmaceuticals Inc | Conditions: Community-acquired Pneumonia, Bacterial Pneumonia | Phase 3 | Status: COMPLETED | Results posted: 2025-04-09